Key Highlights

Zeta Network Group (NASDAQ:ZNB) (down USD 0.0500, 9.07%): Reverse Split Reset Under Pressure

Zeta Network Group (NASDAQ:ZNB) fell 9.07% to USD 0.501 in pre-market trading on November 4, 2026, a drop of USD 0.0500 from the Tuesday close. The prior close was near USD 0.551 (calculated). No press release, regulatory filing or Earnings report dated November 2 to November 4, 2026 was identified, so there is no confirmed catalyst.

An 8-for-1 reverse share split took effect for trading on July 27, 2026, reducing Class A shares outstanding from about 7,758,868 to about 969,859. At USD 0.501 the stock sits below the USD 1.00 Nasdaq bid threshold again. As a penny stock, it faces elevated volatility, thin Liquidity and dilution risk.

Yueda Digital Holding (NASDAQ:YDKG) (down USD 0.0899, 8.99%): USD 1 Level Gives Way

Yueda Digital Holding (NASDAQ:YDKG) fell 8.99% to USD 0.9101 in pre-market trading on November 4, 2026, a decline of USD 0.0899 from an implied prior close of roughly USD 1.00 (calculated). No announcement dated November 2 to November 4, 2026 was identified, so the drop appears consistent with trading in a low-priced, crypto-linked stock.

A regulatory filing dated June 17, 2026 stated that shareholders approved a reverse share consolidation range of 1-for-5 to 1-for-100 on June 12, 2026, alongside a very large increase in authorised capital. The company also announced an initiative called Solon on June 10, 2026, described as a non-custodial control plane for autonomous AI agents that originate on-chain Stablecoin payments. The filing does not report Revenue or funding for it, and the large authorised Capital is a dilution consideration.

Yimutian (NASDAQ:YMT) (down USD 0.0252, 8.39%): Listing Deadline Approaches

Yimutian (NASDAQ:YMT) fell 8.39% to USD 0.275 in pre-market trading on November 4, 2026, a decline of USD 0.0252. No press release, regulatory filing or earnings report dated November 2 to November 4, 2026 was identified, so the cause is unclear. The deadline below may be a factor, but that is an interpretation rather than a company statement.

The company said on May 19, 2026 that it had 180 days, to November 9, 2026, to regain a Nasdaq Market Value requirement, and a hearing request keeps the ADSs trading. Nasdaq confirmed on October 20, 2026 that the stockholders' Equity requirement had been regained. The ADS ratio changed from 1:25 to 1:375 in May 2026, and as a Penny Stock the bid price remains far below USD 1.00.

Cre8 Enterprise (NASDAQ:CRE) (down USD 0.2499, 9.43%): Dip Following a Deal Headline

Cre8 Enterprise (NASDAQ:CRE) fell 9.43% to USD 2.40 in pre-market trading on November 4, 2026, after the company announced on November 3, 2026 that it had completed the Acquisition of a Hong Kong based translation firm. Terms were not available, so any link between the announcement and the pullback cannot be confirmed.

Reported 2025 revenue was HKD 130.93 million, up 26.11%, while Net Income was HKD 5.28 million, down 17.58%. A 1-for-12 Reverse Stock Split was announced on February 11, 2026. The shares trade under USD 5, so volatility, thin liquidity and dilution risk all apply.

Wellchange (NASDAQ:WCT) (down USD 0.0207, 7.54%): Offering Overhang

Wellchange Holdings Company Limited (NASDAQ:WCT) fell 7.54% to USD 0.2538 in pre-market trading on November 4, 2026. No company press release or regulatory filing dated November 2 to November 4, 2026 was identified as a catalyst. The stock closed at USD 0.7001 on October 12, 2026 after a 28.29% one-day drop, and the pre-market price is about 64% below that close (calculated).

A filing dated August 11, 2026 covers up to 50 million Class A shares at an assumed price of USD 0.16, against 2,905,328 outstanding. For 2025, revenue fell 41.6% to USD 1.35 million and the net loss was USD 7.32 million, with cash of USD 2.81 million. A 400 for 1 consolidation approved on July 6, 2026 had not been effected as of that filing, and whether it has since taken effect was not confirmed.

Where Things Stand

All five names are small, low priced stocks with ties to Hong Kong or China, and four of the five have no announcement from the past few days that explains the drop. Only Cre8 Enterprise has a dated headline, and its terms were not available. Common threads are bid price pressure, reverse splits and dilution risk. Watch for Nasdaq correspondence, the November 9, 2026 Yimutian date, Cre8 deal filings and any Wellchange offering pricing.